Antitubercular drugs: possible role of natural products acting as antituberculosis medication in overcoming drug resistance and drug-induced hepatotoxicity

被引:4
作者
Rana, Harvesh Kumar [1 ,2 ]
Singh, Amit Kumar [1 ,3 ]
Kumar, Ramesh [1 ,4 ]
Pandey, Abhay K. [1 ]
机构
[1] Univ Allahabad, Dept Biochem, Allahabad 211002, Uttar Pradesh, India
[2] Feroze Gandhi Postgrad Coll, Dept Zool, Raebareli 229001, India
[3] BMK Govt Girls Coll, Dept Bot, Balod 491226, Chhattisgarh, India
[4] Cent Univ Punjab, Dept Biochem, Bathinda 151401, Punjab, India
关键词
Tuberculosis; Drug-resistance; Hepatoprotective; Natural products; Liver injury;
D O I
10.1007/s00210-023-02679-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mycobacterium tuberculosis (Mtb) is a pathogenic bacterium which causes tuberculosis (TB). TB control programmes are facing threats from drug resistance. Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mtb strains need longer and more expensive treatment with many medications resulting in more adverse effects and decreased chances of treatment outcomes. The World Health Organization (WHO) has emphasised the development of not just new individual anti-TB drugs, but also novel medication regimens as an alternative treatment option for the drug-resistant Mtb strains. Many plants, as well as marine creatures (sponge; Haliclona sp.) and fungi, have been continuously used to treat TB in various traditional treatment systems around the world, providing an almost limitless supply of active components. Natural products, in addition to their anti-mycobacterial action, can be used as adjuvant therapy to increase the efficacy of conventional anti-mycobacterial medications, reduce their side effects, and reverse MDR Mtb strain due to Mycobacterium's genetic flexibility and environmental adaptation. Several natural compounds such as quercetin, ursolic acid, berberine, thymoquinone, curcumin, phloretin, and propolis have shown potential anti-mycobacterial efficacy and are still being explored in preclinical and clinical investigations for confirmation of their efficacy and safety as anti-TB medication. However, more high-level randomized clinical trials are desperately required. The current review provides an overview of drug-resistant TB along with the latest anti-TB medications, drug-induced hepatotoxicity and oxidative stress. Further, the role and mechanisms of action of first and second-line anti-TB drugs and new drugs have been highlighted. Finally, the role of natural compounds as anti-TB medication and hepatoprotectants have been described and their mechanisms discussed.
引用
收藏
页码:1251 / 1273
页数:23
相关论文
共 46 条
  • [41] Cellular efflux transporters and the potential role of natural products in combating efflux mediated drug resistance
    Ayaz, Muhammad
    Subhan, Fazal
    Sadiq, Abdul
    Ullah, Farhat
    Ahmed, Jawad
    Sewell, Robert D. E.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2017, 22 : 732 - 756
  • [42] Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India
    Gupta, Vinod H.
    Amarapurkar, Deepak N.
    Singh, Meenakshi
    Sasi, Preetha
    Joshi, Jyotsna M.
    Baijal, Rajiv
    Ramegowda, Praveenkumar H.
    Amarapurkar, Anjali D.
    Joshi, Kalpana
    Wangikar, Pramod P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (08) : 1368 - 1374
  • [43] Influence of glutathione S-transferase M1 and T1 homozygous null mutations on the risk of antituberculosis drug-induced hepatotoxicity in a Caucasian population
    Leiro, Virginia
    Fernandez-Villar, Alberto
    Valverde, Diana
    Constenla, Lucia
    Vazquez, Rafael
    Pineiro, Luis
    Gonzalez-Quintela, Arturo
    LIVER INTERNATIONAL, 2008, 28 (06) : 835 - 839
  • [44] Exploring the interplay of natural products and long non-coding RNAs in colorectal cancer: pathogenesis, diagnosis, and overcoming drug resistance
    Elimam, Hanan
    Eldeib, Mahmoud Gomaa
    Kizilaslan, Esma Z.
    Alhamshry, Nora A. A.
    Ashour, Abdelkader E.
    Elfar, Nourhan
    Abdel-Wahab, Maie M.
    Zaki, Mohamed Bakr
    Mohammed, Osama A.
    Radwan, Abdullah F.
    Abdel-Reheim, Mustafa Ahmed
    Moussa, Rewan
    Doghish, Ahmed S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025, 398 (02) : 1243 - 1263
  • [45] PHARMACODYNAMICS OF NEW NATURAL DRUGS AGAINST HORMONAL FUNCTION OF THE THYROID GLAND IN INDUCED DRUG RESISTANCE OF TUMORS
    Rakhimov, K. D.
    Adekenov, S. M.
    BULLETIN OF THE NATIONAL ACADEMY OF SCIENCES OF THE REPUBLIC OF KAZAKHSTAN, 2015, (06): : 91 - 95
  • [46] Update meta-analysis of the CYP2E1 RsaI/PstI and DraI polymorphisms and risk of antituberculosis drug-induced hepatotoxicity: evidence from 26 studies
    Wang, F. -J.
    Wang, Y.
    Niu, T.
    Lu, W. -X.
    Sandford, A. J.
    He, J. -Q.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (03) : 334 - 340